Multiple sclerosis and Facial nerve disorder

---

Gender of people who have Multiple Sclerosis and experienced Facial Nerve Disorder *:

• female: 80.56 %
• male: 19.44 %

Age of people who have Multiple Sclerosis and experienced Facial Nerve Disorder *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 4.35 %
• 20-29: 26.09 %
• 30-39: 34.78 %
• 40-49: 4.35 %
• 50-59: 17.39 %
• 60+: 13.04 %

Common co-existing conditions for these people *:

1. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 2.78%
2. Muscle Spasms (muscle contraction): 1 person, 2.78%
3. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 2.78%

Common drugs taken by these people *:

1. Gilenya: 9 people, 25.00%
2. Cymbalta: 8 people, 22.22%
3. Extavia: 8 people, 22.22%
4. Gabapentin: 5 people, 13.89%
5. Tysabri: 3 people, 8.33%
6. Avonex: 3 people, 8.33%
7. Tecfidera: 3 people, 8.33%
8. Temazepam: 2 people, 5.56%
9. Betaseron: 2 people, 5.56%
10. Furosemide: 1 person, 2.78%

Common symptoms for these people *:

1. Vision Blurred: 14 people, 38.89%
2. Headache (pain in head): 12 people, 33.33%
3. Facial Pain: 11 people, 30.56%
4. Fall: 9 people, 25.00%
5. Injection Site Erythema (redness at injection site): 9 people, 25.00%
6. Cartilage Injury: 8 people, 22.22%
7. Injection Site Cyst: 8 people, 22.22%
8. Injection Site Swelling: 8 people, 22.22%
9. Bone Disorder: 8 people, 22.22%
10. Bone Cyst: 8 people, 22.22%

Do you take medications and have Facial nerve disorder?

- Check whether Facial nerve disorder is associated with a drug or a condition